Now showing items 1-5 of 5

    • Santolaya de Pablo, María Elena; Alvarez, Ana M.; Avilés, Carmen L.; Becker, Ana; Mosso, Claudio; O'Ryan Gallardo, Miguel; Payá, Ernesto; Salgado, Carmen; Silva, Pamela; Topelberg, Santiago; Tordecilla, Juan; Varas, Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela (2007)
      BACKGROUND: Early identification of children with cancer at risk for death during a febrile neutropenic (FN) episode may increase their possibility for survival. Our aim was to identify at the time of admission, clinical ...
    • Kogan, Ricardo; Martínez, M. Angélica; Rubilar, Lilian; Payá, Ernesto; Quevedo, Ilsa; Puppo, Homero; Girardi, Guido; Castro-Rodriguez, José A. (2003)
      Our objective was to compare the clinical efficacy of azithromycin vs. erythromycin and amoxicillin in the treatment of presumed bacterial community-acquired pneumonia in ambulatory children, and to evaluate the etiologies ...
    • Lucero, Yalda; Brücher, Roberto; Alvarez, Ana María; Becker, Ana; Cofré, José; Enríquez, Nancy; Payá, Ernesto; Salgado, Carmen; Santolaya de Pablo, María Elena; Tordecilla, Juan; Varas, Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela; O'Ryan Gallardo, Miguel (2002)
      BACKGROUND: Invasive fungal infections (IFI) cause prolonged hospitalizations and increase the possibility of death among patients with cancer and febrile neutropenia (FN). Up to 10% of febrile neutropenic episodes may be ...
    • Payá, Ernesto; Noemí, Isabel; Tassara, Renzo; Catalán, Paula; Avilés, Carmen L. (2012)
      Toxoplasmosis is a widely distributed zoonosis produced by the parasite T. gondii. In Chile the seroprevalence has been estimated between 20-37% in general population. Defined risk groups acquire or reactivate the infection ...
    • Ferrés Garrido, Marcela; Lafourcade, Mónica; Gambra, Pilar; Cerón, Inés; Payá, Ernesto; Oddó, David (Sociedad Chilena de Infectologia, 2019)
      The confrontation of the differential and etiological diagnosis of the infectious diseases of cancer patients, including hematopoietic stem cells transplant (HSCT) recipients, must correspond to an informed, timely decision ...